Director sold
~$11.3MReported value · 425K sh @ $26.67
A board member of Roivant Sciences sold $11.3M of Roivant Sciences shares. Nobody planned it ahead of time.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
CEO exercised or converted 200K ROIV derivative securities
Traded Jan 12, 2026 · Filed Jan 15, 2026
- 200K
- Shares · @ $3.85
Why it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jan 12, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jan 15, 2026
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001140361-26-001239